ATE137976T1 - Verfahren zur reinigung eines 69000 dalton antigenischen proteins aus bordetella pertussis - Google Patents

Verfahren zur reinigung eines 69000 dalton antigenischen proteins aus bordetella pertussis

Info

Publication number
ATE137976T1
ATE137976T1 AT90120662T AT90120662T ATE137976T1 AT E137976 T1 ATE137976 T1 AT E137976T1 AT 90120662 T AT90120662 T AT 90120662T AT 90120662 T AT90120662 T AT 90120662T AT E137976 T1 ATE137976 T1 AT E137976T1
Authority
AT
Austria
Prior art keywords
bordetella pertussis
purifying
dalton
antigenic protein
protein
Prior art date
Application number
AT90120662T
Other languages
English (en)
Inventor
John William Gotto
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ATE137976T1 publication Critical patent/ATE137976T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • Y10S530/825Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT90120662T 1989-12-11 1990-10-29 Verfahren zur reinigung eines 69000 dalton antigenischen proteins aus bordetella pertussis ATE137976T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/448,777 US5276142A (en) 1989-12-11 1989-12-11 Process for purification of a 69000 dalton antigenic protein from Bordetella pertussis

Publications (1)

Publication Number Publication Date
ATE137976T1 true ATE137976T1 (de) 1996-06-15

Family

ID=23781640

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90120662T ATE137976T1 (de) 1989-12-11 1990-10-29 Verfahren zur reinigung eines 69000 dalton antigenischen proteins aus bordetella pertussis

Country Status (13)

Country Link
US (1) US5276142A (de)
EP (1) EP0437687B1 (de)
JP (1) JP2950970B2 (de)
KR (1) KR0180527B1 (de)
AT (1) ATE137976T1 (de)
AU (1) AU641711B2 (de)
CA (1) CA2031763A1 (de)
DE (1) DE69027013T2 (de)
DK (1) DK0437687T3 (de)
ES (1) ES2087109T3 (de)
FI (1) FI101380B1 (de)
NO (1) NO301717B1 (de)
SG (1) SG54177A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8412207D0 (en) * 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
GB8910570D0 (en) * 1989-05-08 1989-06-21 Wellcome Found Acellular vaccine
US6197548B1 (en) 1990-04-02 2001-03-06 Medeva Pharma Limited Transformed Pichia expressing the pertactin antigen
GB9007657D0 (en) * 1990-04-04 1990-05-30 Connaught Lab Purification of a pertussis outer membrane protein(omp69)
EP0484621A3 (en) * 1990-07-11 1992-08-26 American Cyanamid Company Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens
US6444211B2 (en) 1991-04-03 2002-09-03 Connaught Laboratories, Inc. Purification of a pertussis outer membrane protein
GB9304399D0 (en) * 1993-03-04 1993-04-21 Smithkline Beecham Biolog Novel process
DE69511392T2 (de) * 1994-04-28 2000-03-23 Takeda Chemical Industries Ltd Verfahren zur trennung von protektiven verbindungen aus bordetella pertussis
DE19512346C1 (de) * 1995-04-01 1996-06-13 Behringwerke Ag Verfahren zur Reinigung von Filamenthämagglutinin und Pertussis-Toxin
US5877298A (en) * 1995-05-04 1999-03-02 Connaught Lab Acellular pertussis vaccines and methods of preparing thereof
EP1233022B1 (de) 1995-05-04 2015-12-09 Aventis Pasteur Limited Verfahren zur Herstellung von Komponenten azellulären Pertussis-Impfstoffen
GB9611501D0 (en) * 1996-06-03 1996-08-07 Smithkline Beecham Biolog Vaccine compositions
EP1762246A1 (de) 1996-07-02 2007-03-14 Sanofi Pasteur Limited Vielwertige DTP-Polio-Impfstoffe
US8574589B2 (en) * 2009-05-11 2013-11-05 Novartis Ag Antigen purification process for pertactin antigen
CN102584958A (zh) * 2012-02-08 2012-07-18 北京天坛生物制品股份有限公司 百日咳杆菌69kd外膜蛋白的纯化方法
DK2863943T3 (en) 2013-03-08 2016-11-07 Janssen Vaccines & Prevention Bv acellular pertussis vaccines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4220717A (en) * 1977-12-22 1980-09-02 American Cyanamid Company Isolation and purification of polyribosyl ribitol phosphate from Haemophilus influenzae type b.
GB8412207D0 (en) * 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
GB8512972D0 (en) * 1985-05-22 1985-06-26 Univ Glasgow Vaccine production
DK175379B1 (da) * 1987-09-28 2004-09-20 Pfizer Anvendelse af transmitterbart svine-gastro-enteritisvirus samt fremgangsmåde til fremstilling af en vaccine
US5101014A (en) * 1989-02-10 1992-03-31 United States Of America Process for the purification of a 69,000 da outer membrane protein of Bordetella pertussis

Also Published As

Publication number Publication date
JP2950970B2 (ja) 1999-09-20
NO905324D0 (no) 1990-12-10
EP0437687A2 (de) 1991-07-24
FI101380B (fi) 1998-06-15
DE69027013D1 (de) 1996-06-20
FI101380B1 (fi) 1998-06-15
DK0437687T3 (da) 1996-06-03
US5276142A (en) 1994-01-04
FI906071A (fi) 1991-06-12
KR910012234A (ko) 1991-08-07
NO905324L (no) 1991-06-12
KR0180527B1 (ko) 1999-04-01
CA2031763A1 (en) 1991-06-12
AU6793390A (en) 1991-06-13
DE69027013T2 (de) 1996-12-19
SG54177A1 (en) 1998-11-16
NO301717B1 (no) 1997-12-01
EP0437687A3 (en) 1991-07-31
JPH03191789A (ja) 1991-08-21
FI906071A0 (fi) 1990-12-10
ES2087109T3 (es) 1996-07-16
EP0437687B1 (de) 1996-05-15
AU641711B2 (en) 1993-09-30

Similar Documents

Publication Publication Date Title
ATE137976T1 (de) Verfahren zur reinigung eines 69000 dalton antigenischen proteins aus bordetella pertussis
ATE32102T1 (de) Verfahren zum extrahieren von poly-betahydroxybutyraten mittels eines loesungsmittels aus einer waessrigen suspension von mikroorganismen.
FI901646A0 (fi) Kiteinen 2-O- -D-glukopyranosyyli-L-askorbiinihappo ja menetelmä sen valmistamiseksi
ATE192486T1 (de) Chondroitinase, herstellungsverfahren und pharmazeutische zusammensetzung
DE69007854D1 (de) Verfahren und Apparatur zur Herstellung eines oxydsupraleitenden Drahtes.
ATE122054T1 (de) Verfahren zur herstellung eines intravenös verträglichen immunglobulin-g-präparates.
DE3667489D1 (de) Verfahren zur herstellung eines proteins.
DE3650135D1 (de) Proteingewinnung.
FR2630438B1 (fr) Nouvelles p-phenylenediamines, leur procede de preparation, composition tinctoriale les contenant et procede de teinture correspondant
ATE161013T1 (de) Verfahren zum reinigen von 20 cs)-camptothecin
DE69010117D1 (de) Verfahren zur einfachen wiedergewinnung eines adsorbierbaren gases aus einem das adsorbierbare gas in niedriger konzentration enthaltenden gas.
ATE154033T1 (de) Verfahren zur reinigung von proteinen
DE3382177D1 (de) Verfahren und vorrichtung zur herstellung eines strichkodierten etiketts.
DE69112750D1 (de) Verfahren zur Gewinnung von Teicoplanin.
DE3782356D1 (de) Reinigungsverfahren der proteischen antigene von bordetella-bakterien zur gewinnung eines azellularen vakzins.
DE69025375D1 (de) Verfahren
EP0090660A3 (de) Neisseria Gonorrhöe Vakzin
ATA7285A (de) Verfahren zur herstellung von polydispersen nativen pseudomonas-flagella(h)-antigenen (fag)
DE3874468D1 (de) Verfahren zur herstellung eines jasminextraktes und der so gewonnene extrakt.
DE69009428D1 (de) Verfahren zur Herstellung eines Pfirsichblätterextraktes und dessen Verwendung als Badezusatz.
ATE123001T1 (de) Verfahren zur abtrennung von yttrium.
DE59509857D1 (de) Verfahren zur Herstellung molekulareinheitlicher hyperpolymerer Hämoglobine
DE3786947D1 (de) Mikrobiologisches verfahren zur gewinnung eines proteins durch zuechtung eines mutanten bakterienstammes.
DE3676899D1 (de) Verfahren zur herstellung von n-methyl-lysergol.
Robb Separation of tetanus toxin and toxoid proteins by Sephadex gel

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee